StockData

Adagio Medical vs AngioDynamics

ADGM and ANGO side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ADGM and ANGO compare

AngioDynamics is the larger company, worth 12 times as much as Adagio Medical ($504M against $40.4M).

AngioDynamics scores higher on the StockData Score (12 against 1 for Adagio Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricADGMANGO
Size and price
Market cap$40.4M$504M
Share price$1.82$11.98
Change, 1 year109%−5.0%
Change, 5 years−99.4%−58.0%
Beta (5Y)–0.34
Employees41632
StockData Score
Total score112 (better)
Valuation score02 (better)
Growth score02 (better)
Performance score03 (better)
Health score15 (better)
Dividend score00
Valuation
P/S–1.5×
P/B–3.1×
P/FCF–349×
FCF yield−41.0%0.29% (better)
Fair value–$13.24
Margin of safety–9.5%
Growth
Revenue growth (TTM)–8.2%
Revenue growth, 5Y average–1.9%
Profitability
Gross margin–55.7%
Operating margin–−11.2%
Net margin–−10.1%
FCF margin–0.44%
Return on equity−658%−19.2% (better)
Return on invested capital–−21.4%
Financial health
Debt / equity–0.00
Interest coverage−6.4×–
Current ratio1.412.40 (better)
Altman Z-score−5.632.40 (better)
Piotroski F-score–5
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions67.9%91.0%
Held by insiders45.7%5.8%
Insider net buying, 12 months$244K (better)−$655K
Short interest, % of float1.3%5.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.